Moss Adams Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Moss Adams Wealth Advisors's REGN Position: Q2 2026 in Review
Moss Adams Wealth Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 1.1% in Q2 2026, buying an estimated $10.9K and bringing the position to 1,513 shares worth $943K. The position accounts for 0.06% of the portfolio, ranked #101.
Moss Adams Wealth Advisors first reported a position in REGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.16M in Q1 2026. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Moss Adams Wealth Advisors held 1,513 shares of Regeneron Pharmaceuticals worth $943K as of Q2 2026.
- Moss Adams Wealth Advisors bought 16 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $10.9K.
- Regeneron Pharmaceuticals made up 0.06% of Moss Adams Wealth Advisors's portfolio in Q2 2026, its #101 holding.
- Moss Adams Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
- Moss Adams Wealth Advisors's Regeneron Pharmaceuticals position peaked at $1.16M in Q1 2026.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Moss Adams Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.